Eurofins Spinnovation Analytical is a Contract Research Organization specialized in delivering high-end analytical services to the Life Science Industry. Our core activity focuses on addressing your needs in process and drug development, product characterization, manufacturing process optimization and troubleshooting, QC/QA Testing, and batch release of your API and Biologics.
We give you access to our GMP-compliant technology platform which notably includes NMR,
LC-(UV)-MS, ICP-OES and solid-state technologies (ssNMR, XRD, DSC, TGA, DVS).
Key expertise at Eurofins Spinnovation Analytical:
- NMR characterization and QC testing, GMP compliant
- Center of Excellence for solid-state characterization (Solid-state NMR, XRD, DSC, TGA, DVS)
- Spent media analysis (Spedia-NMR™)
- Bioprocess variability testing (Spedia-Predict™)
- Biologics characterization
The company is constituted of 2 divisions:
Spinnovation Analytical focuses on delivering GMP-compliant analysis and analytical R&D to the “small molecule” and traditional pharmaceutical industry.
Spinnovation Biologics delivers advanced analytical solutions for spent media analysis, bioprocess and biologics characterization to the BioPharma and Biotech industry. The unique NMR services at Spinnovation Biologics help Biotech companies optimize, troubleshoot and file bioprocesses.
Since 2014 Spinnovation is part of Sinensis Life Sciences B.V. In 2016 Eurofins, the global market leader in contract analytical services for the food, pharma and environment industry, acquires Sinensis Life Sciences B.V. Under the umbrella of Eurofins BioPharma Product Testing Netherlands each site operates as a business unit, independently providing services to the market.